KLRA
Kailera Therapeutics, Inc. · Healthcare
Bain Capital Life Sciences Investors, LLC bought $25.0M of Kailera Therapeutics, Inc.
10% owner
Bought$25,000,000
$16.00Price
1,562,500Shares
+7%Stake
What KLRA did for a copier
- $1,000 copied at Tue, Apr 21 open, $24.87
- $900
- S&P 500, same days
- +6.2%
Measured over 30 trading days, to the Jun 3 close.
Bain Capital Life Sciences Investors, LLC's record
3 other buys with 3 months of prices since 2017: on average −39.8% against the S&P 500, and 0 of 3 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Apr 20. Filed Mon, Apr 20, 6:01 PM ET, after the close. Returns use the Apr 21 open and the Jun 3 close. Not investment advice.